gamma-aminobutyric acid has been researched along with Stroke in 82 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pregabalin has demonstrated efficacy in several forms of neuropathic pain, but its long-term efficacy in central post-stroke pain (CPSP) is unproven." | 9.15 | Safety and efficacy of pregabalin in patients with central post-stroke pain. ( Bashford, G; Cheung, R; Dror, V; Kim, JS; Martin, A; Murphy, KT, 2011) |
| "The study was designed to compare the efficacy of pregabalin, an anticonvulsant on pain behavior of stroke patients with shoulder pain in a comparative study with ultrasound therapy and ultimately to recommend a better treatment option to improve pain and function in post stroke shoulder pain." | 7.80 | Comparative efficacy of pregabalin and therapeutic ultrasound versus therapeutic ultrasound alone on patients with post stroke shoulder pain. ( Rahman, MS; Uddin, MT, 2014) |
| "Pregabalin, a Ca(2+) channel α(2)δ-subunit antagonist with analgesic and antiepileptic activity, reduced neuronal loss and improved functional outcome in a mouse model of focal ischemic stroke." | 7.77 | Pregabalin suppresses calcium-mediated proteolysis and improves stroke outcome. ( Greig, NH; Lee, JH; Mattson, MP; Mughal, MR; Son, TG; Yoon, JS, 2011) |
| "We present 2 patients with severe and intractable central poststroke pain (CPSP) after right posterolateral thalamic infarcts who were successfully treated with zonisamide." | 7.72 | Successful use of zonisamide for central poststroke pain. ( Hashimoto, K; Takahashi, Y; Tsuji, S, 2004) |
| "Although gabapentin was originally developed for treating partial seizures, it has been used mainly to treat various peripheral neuropathic pain conditions; however, there is very limited experience with gabapentin for the treatment of pain conditions of the central nervous system like central post-stroke pain syndrome." | 7.71 | Central post-stroke pain syndrome: yet another use for gabapentin? ( Chen, B; DeLisa, JA; Foye, PM; Nadler, SF; Stitik, TP, 2002) |
| "The effects of aniracetam, a cognition enhancer, on extracellular levels of glutamate (Glu), gamma-aminobutyric acid (GABA) and nitric oxide metabolites (NOx) were examined in the prefrontal cortex (PFC) and the basolateral amygdala (AMG) in stroke-prone spontaneously hypertensive rats (SHRSP) using in vivo microdialysis." | 7.71 | Aniracetam enhances glutamatergic transmission in the prefrontal cortex of stroke-prone spontaneously hypertensive rats. ( Matsumoto, M; Nakamura, K; Ohashi, S; Saito, H; Togashi, H; Ueno, K; Yoshioka, M, 2002) |
| " Adverse events were more frequent with pregabalin than with placebo and caused discontinuation in 9 (8." | 6.76 | Safety and efficacy of pregabalin in patients with central post-stroke pain. ( Bashford, G; Cheung, R; Dror, V; Kim, JS; Martin, A; Murphy, KT, 2011) |
| "Gabapentin monotherapy was useful and safe for late poststroke ES." | 6.70 | Gabapentin in late-onset poststroke seizures. ( Alvarez-Sabín, J; Codina, A; Molina, CA; Montaner, J; Padró, L; Quintana, M; Rovira, R, 2002) |
| "Stroke is a frequent cause of epileptic seizures (ES) in adults." | 6.70 | Gabapentin in late-onset poststroke seizures. ( Alvarez-Sabín, J; Codina, A; Molina, CA; Montaner, J; Padró, L; Quintana, M; Rovira, R, 2002) |
| "We measured 4 plasma amino acid neurotransmitters (glutamic acid, aspartic acid, gamma-aminobutyric acid, and glycine) among 3486 patients with ischemic stroke from 26 hospitals across China." | 5.69 | Plasma Amino Acid Neurotransmitters and Ischemic Stroke Prognosis: A Multicenter Prospective Study. ( Chen, J; Guo, D; He, J; Jia, Y; Peng, H; Shi, M; Sun, L; Wang, A; Wang, Y; Xu, Q; Xu, T; Yang, P; Zhang, Y; Zhong, C; Zhu, Z, 2023) |
| "Increased glutamic acid, aspartic acid, and gamma-aminobutyric acid and decreased glycine in plasma are associated with adverse outcomes after ischemic stroke, suggesting that plasma amino acid neurotransmitters may be potential intervention targets for improving prognosis of ischemic stroke." | 5.69 | Plasma Amino Acid Neurotransmitters and Ischemic Stroke Prognosis: A Multicenter Prospective Study. ( Chen, J; Guo, D; He, J; Jia, Y; Peng, H; Shi, M; Sun, L; Wang, A; Wang, Y; Xu, Q; Xu, T; Yang, P; Zhang, Y; Zhong, C; Zhu, Z, 2023) |
| "Central poststroke pain is a neuropathic pain syndrome that can occur from pathology of the brain." | 5.43 | A Medication Combination for the Treatment of Central Poststroke Pain via the Adjuvant Use of Prednisone With Gabapentin: A Case Report. ( Batlle, L; Irwin, R; Mattie, R, 2016) |
| "Treatment with gabapentin was initiated, with good results at 6-month follow-up." | 5.31 | Gabapentin treatment in a child with delayed-onset hemichorea/hemiballismus. ( Kothare, SV; Kulberg, AG; Pollack, P; Ravin, PD, 2000) |
| " Stroke Impairment Assessment Set (SIAS) was adopted to assess the whole function status after sroke, and the contents of glutamate (Glu) and gamma-aminobutyric acid (GABA) in serum and clinical efficacy were observed in the two groups." | 5.16 | [Comparative study on effects between electroacupuncture and acupuncture for spastic paralysis after stroke]. ( Chang, XR; Chen, LL; Jiang, JM; Li, L; Yue, ZH; Zhu, XS, 2012) |
| "Pregabalin has demonstrated efficacy in several forms of neuropathic pain, but its long-term efficacy in central post-stroke pain (CPSP) is unproven." | 5.15 | Safety and efficacy of pregabalin in patients with central post-stroke pain. ( Bashford, G; Cheung, R; Dror, V; Kim, JS; Martin, A; Murphy, KT, 2011) |
| "This review provides moderate-quality evidence that fails to support the use of GABA receptor agonists (chlormethiazole or diazepam) for the treatment of people with acute stroke." | 4.98 | Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. ( Liu, J; Wang, LN; Zhang, J, 2018) |
| " However, two randomised placebo-controlled studies have recently emerged demonstrating efficacy of pregabalin in reducing central neuropathic pain due to spinal cord injury and central poststroke pain." | 4.84 | Pregabalin in the management of central neuropathic pain. ( Gray, P, 2007) |
| "In patients with diabetic neuropathy who were prescribed gabapentin and pregabalin, there is an increased risk for heart failure, myocardial infarction, peripheral vascular disease, stroke, deep venous thrombosis, and pulmonary embolism with long-term use." | 4.12 | Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. ( Blankfield, RP; Davis, PB; Kaebler, DC; Pan, Y; Xu, R, 2022) |
| "Gabapentin and pregabalin are commonly prescribed medications to treat pain in patients with diabetic neuropathy." | 4.12 | Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. ( Blankfield, RP; Davis, PB; Kaebler, DC; Pan, Y; Xu, R, 2022) |
| "The study was designed to compare the efficacy of pregabalin, an anticonvulsant on pain behavior of stroke patients with shoulder pain in a comparative study with ultrasound therapy and ultimately to recommend a better treatment option to improve pain and function in post stroke shoulder pain." | 3.80 | Comparative efficacy of pregabalin and therapeutic ultrasound versus therapeutic ultrasound alone on patients with post stroke shoulder pain. ( Rahman, MS; Uddin, MT, 2014) |
| "We have reported that in rats with a 90 min left middle cerebral artery occlusion (MCAO) and 24 h reperfusion, pressor responses during muscle contractions were attenuated, as were glutamate concentrations in the left rostral ventrolateral medulla (RVLM) and left caudal VLM (CVLM), but gamma-aminobutyric acid (GABA) levels increased in left RVLM and CVLM." | 3.79 | Effects of medullary administration of a nitric oxide precursor on cardiovascular responses and neurotransmission during static exercise following ischemic stroke. ( Ally, A; Maher, TJ; Phattanarudee, S; Towiwat, P, 2013) |
| "Pregabalin, a Ca(2+) channel α(2)δ-subunit antagonist with analgesic and antiepileptic activity, reduced neuronal loss and improved functional outcome in a mouse model of focal ischemic stroke." | 3.77 | Pregabalin suppresses calcium-mediated proteolysis and improves stroke outcome. ( Greig, NH; Lee, JH; Mattson, MP; Mughal, MR; Son, TG; Yoon, JS, 2011) |
| "We present 2 patients with severe and intractable central poststroke pain (CPSP) after right posterolateral thalamic infarcts who were successfully treated with zonisamide." | 3.72 | Successful use of zonisamide for central poststroke pain. ( Hashimoto, K; Takahashi, Y; Tsuji, S, 2004) |
| "Experimental studies have suggested that ischemic stroke causes increment in extracellular level of gamma-aminobutyric acid in response to excessive glutamate concentration and function." | 3.72 | GABA in ischemic stroke. Proton magnetic resonance study. ( Głodzik-Sobańska, L; Kozub, J; Sobiecka, B; Szczudlik, A; Słowik, A; Urbanik, A, 2004) |
| "Although gabapentin was originally developed for treating partial seizures, it has been used mainly to treat various peripheral neuropathic pain conditions; however, there is very limited experience with gabapentin for the treatment of pain conditions of the central nervous system like central post-stroke pain syndrome." | 3.71 | Central post-stroke pain syndrome: yet another use for gabapentin? ( Chen, B; DeLisa, JA; Foye, PM; Nadler, SF; Stitik, TP, 2002) |
| "The effects of aniracetam, a cognition enhancer, on extracellular levels of glutamate (Glu), gamma-aminobutyric acid (GABA) and nitric oxide metabolites (NOx) were examined in the prefrontal cortex (PFC) and the basolateral amygdala (AMG) in stroke-prone spontaneously hypertensive rats (SHRSP) using in vivo microdialysis." | 3.71 | Aniracetam enhances glutamatergic transmission in the prefrontal cortex of stroke-prone spontaneously hypertensive rats. ( Matsumoto, M; Nakamura, K; Ohashi, S; Saito, H; Togashi, H; Ueno, K; Yoshioka, M, 2002) |
| "Stroke is a major cause of death and chronic neurological disability." | 3.01 | An integrated measure of GABA to characterize post-stroke plasticity. ( Maquet, P; Paparella, I; Stagg, CJ; Vanderwalle, G, 2023) |
| " Number and type of adverse events were similar between the three groups." | 2.94 | Safety and efficacy of GABA ( Audoli-Inthavong, ML; Bassetti, CL; Chabriat, H; Hermann, DM; Lambert, E; Marx, U; Sors, A; Wattez, M, 2020) |
| " Adverse events were more frequent with pregabalin than with placebo and caused discontinuation in 9 (8." | 2.76 | Safety and efficacy of pregabalin in patients with central post-stroke pain. ( Bashford, G; Cheung, R; Dror, V; Kim, JS; Martin, A; Murphy, KT, 2011) |
| "Gabapentin monotherapy was useful and safe for late poststroke ES." | 2.70 | Gabapentin in late-onset poststroke seizures. ( Alvarez-Sabín, J; Codina, A; Molina, CA; Montaner, J; Padró, L; Quintana, M; Rovira, R, 2002) |
| "Stroke is a frequent cause of epileptic seizures (ES) in adults." | 2.70 | Gabapentin in late-onset poststroke seizures. ( Alvarez-Sabín, J; Codina, A; Molina, CA; Montaner, J; Padró, L; Quintana, M; Rovira, R, 2002) |
| "Stroke is a leading cause of long-term disability, with around three-quarters of stroke survivors experiencing motor problems." | 2.58 | Neurochemical changes underpinning the development of adjunct therapies in recovery after stroke: A role for GABA? ( Hinson, EL; Johnstone, A; Levenstein, JM; Stagg, CJ, 2018) |
| "Somnolence and rhinitis are frequent adverse events related to chlormethiazole." | 2.58 | Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. ( Liu, J; Wang, LN; Zhang, J, 2018) |
| "Central neuropathic pain is a painful condition, often severe, that occurs in a person who is already affected by an injury or disease of the brain or spinal cord." | 2.44 | Pregabalin in the management of central neuropathic pain. ( Gray, P, 2007) |
| "Chronic hiccup is not so rare in patients suffering from stroke: its impact on quality of life and on rehabilitation management is substantial, and it may be closely related to aspiration pneumonia, respiratory arrest and nutritional depletion." | 2.42 | Gabapentin as a drug therapy of intractable hiccup because of vascular lesion: a three-year follow up. ( Antonello, RM; Bava, A; Cazzato, G; Moretti, R; Torre, P; Ukmar, M, 2004) |
| "Because of this cause we decided to treat intractable hiccups in patients with ischemic lesions of the medulla with a short course of gabapentin." | 2.42 | Gabapentin as a drug therapy of intractable hiccup because of vascular lesion: a three-year follow up. ( Antonello, RM; Bava, A; Cazzato, G; Moretti, R; Torre, P; Ukmar, M, 2004) |
| "TTC staining was used to detect cerebral infarction volume, and the brain water content of rats in each group was determined by wet and dry weight method." | 1.91 | [Effects of Governor Vessel electroacupuncture on chloridion homeostasis in the cortex of rats with limb spasm after cerebral ischemia-reperfusion]. ( Guo, J; Li, JW; Li, RQ; Mei, JJ; Wang, YY; Zhang, JY; Zhang, LH, 2023) |
| " However, whether long-term use of gabapentin and pregabalin is associated with adverse cardiovascular diseases remains unknown." | 1.72 | Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. ( Blankfield, RP; Davis, PB; Kaebler, DC; Pan, Y; Xu, R, 2022) |
| "Waggle needling, a classical anti-spastic needling technique characterized by combination of acupuncture with joint movement, has gained increasing popularity of spasticity treatment in China." | 1.56 | Waggle needling wields preferable neuroprotective and anti-spastic effects on post-stroke spasticity rats by attenuating γ-aminobutyric acid transaminase and enhancing γ-aminobutyric acid. ( Gan, YY; Guo, MW; Li, JL; Ma, LX; Mu, JD; Qian, X; Ren, XX; Song, Y; Sun, TY; Tian, Y; Wang, JX; Yu, WY, 2020) |
| "Stroke is a leading cause of adult disability owing largely to motor impairment and loss of function." | 1.51 | The Influence of Primary Motor Cortex Inhibition on Upper Limb Impairment and Function in Chronic Stroke: A Multimodal Study. ( Ackerley, SJ; Barber, PA; Byblow, WD; Cirillo, J; Mooney, RA; Rajeswaran, DK; Stinear, CM, 2019) |
| "Central poststroke pain is a neuropathic pain syndrome that can occur from pathology of the brain." | 1.43 | A Medication Combination for the Treatment of Central Poststroke Pain via the Adjuvant Use of Prednisone With Gabapentin: A Case Report. ( Batlle, L; Irwin, R; Mattie, R, 2016) |
| " We performed unilateral ventralis caudalis deep brain stimulation combined with stereotactic bilateral cingulotomy to maximize the effects of treatment for 3 patients with intractable post-stroke pain." | 1.38 | Impact of ventralis caudalis deep brain stimulation combined with stereotactic bilateral cingulotomy for treatment of post-stroke pain. ( Chang, JW; Chang, WS; Kim, JP; Park, YS, 2012) |
| "Conversely, in painted turtle brain anoxia increases γ-amino butyric acid (GABA)ergic suppression of spontaneous electrical activity, and cell death is prevented." | 1.38 | Painted turtle cortex is resistant to an in vitro mimic of the ischemic mammalian penumbra. ( Buck, LT; Gu, XQ; Haddad, GG; Hogg, DW; Pamenter, ME, 2012) |
| "Stroke is the third leading cause of death worldwide." | 1.38 | Impact of ventralis caudalis deep brain stimulation combined with stereotactic bilateral cingulotomy for treatment of post-stroke pain. ( Chang, JW; Chang, WS; Kim, JP; Park, YS, 2012) |
| "Stroke is a leading cause of disability, but no pharmacological therapy is currently available for promoting recovery." | 1.36 | Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. ( Carmichael, ST; Clarkson, AN; Huang, BS; Macisaac, SE; Mody, I, 2010) |
| "Malignant cerebral infarction (MaCI) treated with mechanical ventilation, mannitol, or barbiturates has a mortality of about 80% and survivors show severe disability." | 1.33 | Prolonged moderate hypothermia in massive hemispheric infarction: clinical experience. ( Escuret, E; Heroum, C; Milhaud, D; Thouvenot, E, 2005) |
| "We introduced intracerebral hemorrhage in each of eight anesthetized New Zealand rabbits by injecting 0." | 1.32 | Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study. ( Ali, Z; Baker, G; Guterman, LR; Hopkins, LN; Qureshi, AI; Shuaib, A; Suri, MF; Todd, K, 2003) |
| "Treatment with gabapentin was initiated, with good results at 6-month follow-up." | 1.31 | Gabapentin treatment in a child with delayed-onset hemichorea/hemiballismus. ( Kothare, SV; Kulberg, AG; Pollack, P; Ravin, PD, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 27 (32.93) | 29.6817 |
| 2010's | 38 (46.34) | 24.3611 |
| 2020's | 17 (20.73) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, QM | 1 |
| Yao, FR | 1 |
| Sun, HW | 1 |
| Chen, ZG | 1 |
| Ke, J | 1 |
| Liao, J | 1 |
| Cai, XY | 1 |
| Yu, LQ | 1 |
| Wu, ZY | 1 |
| Wang, Z | 1 |
| Pan, X | 1 |
| Liu, HY | 1 |
| Li, L | 2 |
| Zhang, QQ | 1 |
| Ling, WH | 1 |
| Fang, Q | 1 |
| Kim, J | 1 |
| Guo, L | 1 |
| Hishinuma, A | 1 |
| Lemke, S | 1 |
| Ramanathan, DS | 1 |
| Won, SJ | 1 |
| Ganguly, K | 1 |
| Mu, JD | 3 |
| Ma, LX | 3 |
| Zhang, Z | 2 |
| Yu, WY | 3 |
| Sun, TY | 3 |
| Qian, X | 3 |
| Tian, Y | 3 |
| Wang, JX | 3 |
| Zhang, YD | 1 |
| Li, JW | 2 |
| Hu, YC | 1 |
| Wang, YY | 2 |
| Mei, JJ | 2 |
| Gao, J | 1 |
| Ren, BB | 1 |
| Feng, XD | 1 |
| Li, RQ | 2 |
| Pan, Y | 1 |
| Davis, PB | 1 |
| Kaebler, DC | 1 |
| Blankfield, RP | 1 |
| Xu, R | 1 |
| Liu, W | 2 |
| He, X | 2 |
| Lin, H | 2 |
| Yang, M | 2 |
| Dai, Y | 2 |
| Chen, L | 4 |
| Li, C | 2 |
| Liang, S | 2 |
| Tao, J | 2 |
| Paparella, I | 1 |
| Vanderwalle, G | 1 |
| Stagg, CJ | 4 |
| Maquet, P | 1 |
| Willis, HE | 1 |
| Ip, IB | 1 |
| Watt, A | 1 |
| Campbell, J | 1 |
| Jbabdi, S | 1 |
| Clarke, WT | 1 |
| Cavanaugh, MR | 1 |
| Huxlin, KR | 1 |
| Watkins, KE | 1 |
| Tamietto, M | 1 |
| Bridge, H | 1 |
| Zhang, LH | 1 |
| Zhang, JY | 1 |
| Guo, J | 1 |
| Zhu, Z | 1 |
| Yang, P | 1 |
| Jia, Y | 1 |
| Wang, Y | 2 |
| Shi, M | 1 |
| Zhong, C | 1 |
| Peng, H | 1 |
| Sun, L | 1 |
| Guo, D | 1 |
| Xu, Q | 2 |
| Chen, J | 3 |
| Wang, A | 1 |
| Xu, T | 1 |
| He, J | 1 |
| Zhang, Y | 2 |
| Chabriat, H | 1 |
| Bassetti, CL | 1 |
| Marx, U | 1 |
| Audoli-Inthavong, ML | 1 |
| Sors, A | 1 |
| Lambert, E | 1 |
| Wattez, M | 1 |
| Hermann, DM | 1 |
| Song, Y | 1 |
| Gan, YY | 1 |
| Guo, MW | 1 |
| Ren, XX | 1 |
| Li, JL | 1 |
| Wan, L | 1 |
| Li, Z | 2 |
| Liu, T | 1 |
| Chen, X | 1 |
| Yao, W | 1 |
| Zhang, C | 1 |
| Esin, RG | 2 |
| Esin, OR | 2 |
| Khakimova, AR | 1 |
| Nam, MH | 1 |
| Cho, J | 1 |
| Kwon, DH | 1 |
| Park, JY | 1 |
| Woo, J | 1 |
| Lee, JM | 1 |
| Lee, S | 1 |
| Ko, HY | 1 |
| Won, W | 1 |
| Kim, RG | 1 |
| Song, H | 1 |
| Oh, SJ | 1 |
| Choi, JW | 1 |
| Park, KD | 1 |
| Park, EK | 1 |
| Jung, H | 1 |
| Kim, HS | 1 |
| Lee, MC | 1 |
| Yun, M | 1 |
| Lee, CJ | 1 |
| Kim, HI | 1 |
| Lin, Y | 1 |
| Yao, M | 1 |
| Wu, H | 1 |
| Wu, F | 1 |
| Cao, S | 1 |
| Ni, H | 1 |
| Dong, J | 1 |
| Yang, D | 1 |
| Sun, Y | 1 |
| Kou, X | 1 |
| Li, J | 1 |
| Xiao, H | 1 |
| Chang, L | 1 |
| Wu, J | 1 |
| Liu, Y | 1 |
| Luo, C | 1 |
| Zhu, D | 1 |
| Daglia, M | 2 |
| Di Lorenzo, A | 2 |
| Nabavi, SF | 2 |
| Sureda, A | 2 |
| Khanjani, S | 2 |
| Moghaddam, AH | 2 |
| Braidy, N | 1 |
| Nabavi, SM | 2 |
| Johnstone, A | 1 |
| Levenstein, JM | 1 |
| Hinson, EL | 1 |
| Roy, M | 1 |
| Sorokina, O | 1 |
| Skene, N | 1 |
| Simonnet, C | 1 |
| Mazzo, F | 1 |
| Zwart, R | 1 |
| Sher, E | 1 |
| Smith, C | 1 |
| Armstrong, JD | 1 |
| Grant, SGN | 1 |
| Orfila, JE | 1 |
| Grewal, H | 1 |
| Dietz, RM | 1 |
| Strnad, F | 1 |
| Shimizu, T | 1 |
| Moreno, M | 1 |
| Schroeder, C | 1 |
| Yonchek, J | 1 |
| Rodgers, KM | 1 |
| Dingman, A | 1 |
| Bernard, TJ | 1 |
| Quillinan, N | 1 |
| Macklin, WB | 1 |
| Traystman, RJ | 1 |
| Herson, PS | 1 |
| Andrushko, JW | 1 |
| Zirk, DT | 1 |
| Liu, J | 1 |
| Zhang, J | 1 |
| Wang, LN | 1 |
| Mooney, RA | 1 |
| Ackerley, SJ | 1 |
| Rajeswaran, DK | 1 |
| Cirillo, J | 1 |
| Barber, PA | 1 |
| Stinear, CM | 1 |
| Byblow, WD | 1 |
| O'Shea, J | 1 |
| Boudrias, MH | 1 |
| Bachtiar, V | 2 |
| Kischka, U | 1 |
| Blicher, JU | 2 |
| Johansen-Berg, H | 1 |
| Phattanarudee, S | 1 |
| Towiwat, P | 1 |
| Maher, TJ | 1 |
| Ally, A | 1 |
| Málly, J | 1 |
| Rahman, MS | 1 |
| Uddin, MT | 1 |
| Yang, F | 4 |
| Fu, H | 2 |
| Lu, YF | 2 |
| Wang, XL | 1 |
| Yang, Y | 2 |
| Yu, YQ | 2 |
| Sun, W | 2 |
| Wang, JS | 1 |
| Costigan, M | 1 |
| Liu, C | 1 |
| Li, R | 1 |
| Song, X | 1 |
| Feng, X | 1 |
| Shao, B | 1 |
| Zhou, YL | 1 |
| Wang, H | 1 |
| Lin, YS | 1 |
| Kurzepa, J | 1 |
| Szpetnar, M | 1 |
| Hordyjewska, A | 1 |
| Wątroba, S | 1 |
| Gołąb, P | 1 |
| Boguszewska-Czubara, A | 1 |
| Duan, CL | 1 |
| Liu, CW | 1 |
| Shen, SW | 1 |
| Yu, Z | 1 |
| Mo, JL | 1 |
| Chen, XH | 1 |
| Sun, FY | 1 |
| Fleming, GF | 1 |
| Sitnova, MA | 1 |
| Modi, JP | 1 |
| Prentice, H | 1 |
| Wu, JY | 1 |
| Batlle, L | 1 |
| Mattie, R | 1 |
| Irwin, R | 1 |
| Mäkelä, JP | 1 |
| Lioumis, P | 1 |
| Laaksonen, K | 1 |
| Forss, N | 1 |
| Tatlisumak, T | 1 |
| Kaste, M | 1 |
| Mustanoja, S | 1 |
| Arcidiaco, P | 1 |
| Li, CL | 1 |
| He, T | 1 |
| Wang, RR | 1 |
| Pennisi, E | 1 |
| Jakobsen, J | 1 |
| Andersen, G | 1 |
| Nielsen, JF | 1 |
| Carlsson, KC | 1 |
| Savić, RM | 1 |
| Hooker, AC | 1 |
| Karlsson, MO | 1 |
| Hummel, FC | 1 |
| Steven, B | 1 |
| Hoppe, J | 1 |
| Heise, K | 1 |
| Thomalla, G | 1 |
| Cohen, LG | 1 |
| Gerloff, C | 1 |
| Gu, W | 1 |
| Gu, C | 1 |
| Jiang, W | 1 |
| Wester, P | 1 |
| Fishell, G | 1 |
| Goldman, JE | 1 |
| Clarkson, AN | 1 |
| Huang, BS | 1 |
| Macisaac, SE | 1 |
| Mody, I | 1 |
| Carmichael, ST | 2 |
| Staley, K | 1 |
| Yoon, JS | 1 |
| Lee, JH | 1 |
| Son, TG | 1 |
| Mughal, MR | 1 |
| Greig, NH | 1 |
| Mattson, MP | 1 |
| Kim, JS | 1 |
| Bashford, G | 1 |
| Murphy, KT | 1 |
| Martin, A | 1 |
| Dror, V | 1 |
| Cheung, R | 1 |
| Attal, N | 1 |
| Chen, WH | 1 |
| Yin, HL | 1 |
| Kim, JP | 1 |
| Chang, WS | 1 |
| Park, YS | 1 |
| Chang, JW | 1 |
| Pamenter, ME | 1 |
| Hogg, DW | 1 |
| Gu, XQ | 1 |
| Buck, LT | 1 |
| Haddad, GG | 1 |
| Yue, ZH | 1 |
| Chang, XR | 1 |
| Jiang, JM | 1 |
| Chen, LL | 1 |
| Zhu, XS | 1 |
| Molinaro, P | 1 |
| Cantile, M | 1 |
| Cuomo, O | 1 |
| Secondo, A | 1 |
| Pannaccione, A | 1 |
| Ambrosino, P | 1 |
| Pignataro, G | 1 |
| Fiorino, F | 1 |
| Severino, B | 1 |
| Gatta, E | 1 |
| Sisalli, MJ | 1 |
| Milanese, M | 1 |
| Scorziello, A | 1 |
| Bonanno, G | 1 |
| Robello, M | 1 |
| Santagada, V | 1 |
| Caliendo, G | 1 |
| Di Renzo, G | 1 |
| Annunziato, L | 1 |
| Chen, B | 1 |
| Stitik, TP | 1 |
| Foye, PM | 1 |
| Nadler, SF | 1 |
| DeLisa, JA | 1 |
| Yager, JY | 1 |
| Hartfield, DS | 1 |
| Alvarez-Sabín, J | 1 |
| Montaner, J | 1 |
| Padró, L | 1 |
| Molina, CA | 1 |
| Rovira, R | 1 |
| Codina, A | 1 |
| Quintana, M | 1 |
| Cincotta, M | 1 |
| Borgheresi, A | 1 |
| Balestrieri, F | 1 |
| Zaccara, G | 1 |
| Yen, HL | 1 |
| Chan, W | 1 |
| Qureshi, AI | 1 |
| Ali, Z | 1 |
| Suri, MF | 1 |
| Shuaib, A | 1 |
| Baker, G | 1 |
| Todd, K | 1 |
| Guterman, LR | 1 |
| Hopkins, LN | 1 |
| Matsko, MA | 1 |
| Ivanova, NE | 1 |
| Hársing, LG | 1 |
| Gigler, G | 1 |
| Albert, M | 1 |
| Szénási, G | 1 |
| Simó, A | 1 |
| Móricz, K | 1 |
| Varga, A | 1 |
| Ling, I | 1 |
| Bagdy, E | 1 |
| Király, I | 1 |
| Sólyom, S | 1 |
| Jurányi, Z | 1 |
| Moretti, R | 1 |
| Torre, P | 1 |
| Antonello, RM | 1 |
| Ukmar, M | 1 |
| Cazzato, G | 1 |
| Bava, A | 1 |
| Takahashi, Y | 1 |
| Hashimoto, K | 1 |
| Tsuji, S | 1 |
| Zádor, Z | 1 |
| Benyó, Z | 1 |
| Lacza, Z | 1 |
| Hortobágyi, T | 2 |
| Harkány, T | 1 |
| Rotella, DP | 1 |
| Milhaud, D | 1 |
| Thouvenot, E | 1 |
| Heroum, C | 1 |
| Escuret, E | 1 |
| Madden, K | 1 |
| Clark, W | 1 |
| Lessov, N | 1 |
| Serena, J | 1 |
| Blanco, M | 1 |
| Castellanos, M | 1 |
| Silva, Y | 1 |
| Vivancos, J | 1 |
| Moro, MA | 1 |
| Leira, R | 1 |
| Lizasoain, I | 1 |
| Castillo, J | 1 |
| Dávalos, A | 1 |
| Głodzik-Sobańska, L | 1 |
| Słowik, A | 1 |
| Kozub, J | 1 |
| Sobiecka, B | 1 |
| Urbanik, A | 1 |
| Szczudlik, A | 1 |
| Choudhuri, I | 1 |
| Sarvananthan, N | 1 |
| Gottlob, I | 1 |
| Lalonde, RL | 1 |
| Kowalski, KG | 1 |
| Hutmacher, MM | 1 |
| Ewy, W | 1 |
| Nichols, DJ | 1 |
| Milligan, PA | 1 |
| Corrigan, BW | 1 |
| Lockwood, PA | 1 |
| Marshall, SA | 1 |
| Benincosa, LJ | 1 |
| Tensfeldt, TG | 1 |
| Parivar, K | 1 |
| Amantea, M | 1 |
| Glue, P | 1 |
| Koide, H | 1 |
| Miller, R | 1 |
| Gray, P | 1 |
| Kothare, SV | 1 |
| Pollack, P | 1 |
| Kulberg, AG | 1 |
| Ravin, PD | 1 |
| Goldstein, LB | 1 |
| Fisher, M | 1 |
| Schaebitz, W | 1 |
| Nelson, RM | 1 |
| Hainsworth, AH | 1 |
| Lambert, DG | 1 |
| Jones, JA | 1 |
| Murray, TK | 1 |
| Richards, DA | 1 |
| Gabrielsson, J | 1 |
| Cross, AJ | 1 |
| Green, AR | 1 |
| Togashi, H | 1 |
| Nakamura, K | 1 |
| Matsumoto, M | 1 |
| Ueno, K | 1 |
| Ohashi, S | 1 |
| Saito, H | 1 |
| Yoshioka, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Efficacy and Safety Trial With Oral S 44819 After Recent Ischemic Cerebral Event. International, Multi-centre, Randomized, Doubleblind Placebo-controlled Phase II Study. (RESTORE BRAIN Study)[NCT02877615] | Phase 2 | 585 participants (Actual) | Interventional | 2016-12-19 | Completed | ||
| An Open Label, Non-Randomized Multisite Phase II Trial Combining Bevacizumab, Atezolizumab and Rucaparib for the Treatment of Previously Treated Recurrent and Progressive Endometrial Carcinoma[NCT03694262] | Phase 2 | 30 participants (Actual) | Interventional | 2019-07-19 | Completed | ||
| Transcranial Direct Current Stimulation on Inhibitory Control in Addictions: a Triple-blinded, Sham-controlled Clinical Trial.[NCT05350033] | 200 participants (Anticipated) | Interventional | 2021-04-05 | Enrolling by invitation | |||
| The Øresund Copenhagen-Malmø Acute Stroke Cooling Trial[NCT01500421] | Phase 2 | 31 participants (Actual) | Interventional | 2008-10-31 | Completed | ||
| Comparison of Oral Gabapentin and Pregabalin in Postoperative Pain Control After Photorefractive Keratectomy: a Prospective, Randomized Study.[NCT00954187] | 8 participants (Actual) | Interventional | 2009-11-30 | Terminated (stopped due to PI left institution) | |||
| Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment: Double Blinded Comparison Between Botulinum Toxin and Baclofen.[NCT02462317] | Phase 4 | 184 participants (Actual) | Interventional | 2015-04-30 | Completed | ||
| Cortex Motor Function Reorganization in Stroke Patients: A Longitudinal fMRI Study[NCT04794673] | 36 participants (Actual) | Observational | 2020-01-12 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
15 reviews available for gamma-aminobutyric acid and Stroke
| Article | Year |
|---|---|
An integrated measure of GABA to characterize post-stroke plasticity.
Topics: gamma-Aminobutyric Acid; Humans; Stroke | 2023 |
Epoxyeicosatrienoic acids: Emerging therapeutic agents for central post-stroke pain.
Topics: Analgesics; Animals; Brain; Chronic Pain; Eicosanoids; gamma-Aminobutyric Acid; Humans; Inflammation | 2020 |
Neurochemical changes underpinning the development of adjunct therapies in recovery after stroke: A role for GABA?
Topics: Animals; Combined Modality Therapy; Electric Stimulation Therapy; gamma-Aminobutyric Acid; Humans; N | 2018 |
Gamma aminobutyric acid (GABA) receptor agonists for acute stroke.
Topics: Acute Disease; Chlormethiazole; Diazepam; Disorders of Excessive Somnolence; GABA Agonists; gamma-Am | 2018 |
Non-invasive brain stimulation (rTMS and tDCS) in patients with aphasia: mode of action at the cellular level.
Topics: Aphasia; Biophysics; Brain; Electric Stimulation Therapy; gamma-Aminobutyric Acid; Glutamic Acid; Hu | 2013 |
The role of inhibition in human motor cortical plasticity.
Topics: Brain; gamma-Aminobutyric Acid; Humans; Learning; Motor Activity; Motor Cortex; Neural Inhibition; N | 2014 |
Second-Line Therapy for Endometrial Cancer: The Need for Better Options.
Topics: Adenocarcinoma; Amines; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Clinical Trials | 2015 |
Brain excitability in stroke: the yin and yang of stroke progression.
Topics: Brain; Cerebral Infarction; Disease Progression; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Lea | 2012 |
Neurologic manifestations of iron deficiency in childhood.
Topics: Anemia, Iron-Deficiency; Brain Diseases; Child; Child, Preschool; Developmental Disabilities; Dopami | 2002 |
Gabapentin as a drug therapy of intractable hiccup because of vascular lesion: a three-year follow up.
Topics: Acetates; Aged; Amines; Brain Stem; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; | 2004 |
[Neuroprotection in brain ischemia--doubts and hopes].
Topics: Animals; Apoptosis; Brain Ischemia; Calcium Channels; Cerebrovascular Circulation; Clinical Trials a | 2004 |
Model-based drug development.
Topics: Alzheimer Disease; Amines; Analgesics; Animals; Anticholesteremic Agents; Bridged Bicyclo Compounds, | 2007 |
Pregabalin in the management of central neuropathic pain.
Topics: Analgesics; Animals; gamma-Aminobutyric Acid; Humans; Multiple Sclerosis; Neuralgia; Pregabalin; Ris | 2007 |
Effects of amphetamines and small related molecules on recovery after stroke in animals and man.
Topics: Amphetamines; Animals; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antihypertensive | 2000 |
Effects of amphetamines and small related molecules on recovery after stroke in animals and man.
Topics: Amphetamines; Animals; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antihypertensive | 2000 |
Effects of amphetamines and small related molecules on recovery after stroke in animals and man.
Topics: Amphetamines; Animals; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antihypertensive | 2000 |
Effects of amphetamines and small related molecules on recovery after stroke in animals and man.
Topics: Amphetamines; Animals; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Antihypertensive | 2000 |
An overview of acute stroke therapy: past, present, and future.
Topics: Acute Disease; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Antibodies; Brain Ischemia; | 2000 |
7 trials available for gamma-aminobutyric acid and Stroke
| Article | Year |
|---|---|
Combining inhibitory and facilitatory repetitive transcranial magnetic stimulation (rTMS) treatment improves motor function by modulating GABA in acute ischemic stroke patients.
Topics: gamma-Aminobutyric Acid; Humans; Ischemic Stroke; Recovery of Function; Stroke; Stroke Rehabilitatio | 2021 |
Plasma Amino Acid Neurotransmitters and Ischemic Stroke Prognosis: A Multicenter Prospective Study.
Topics: Aspartic Acid; Biomarkers; Brain Ischemia; Cohort Studies; gamma-Aminobutyric Acid; Glutamic Acid; G | 2023 |
Safety and efficacy of GABA
Topics: Adult; Aged; Aged, 80 and over; Benzodiazepines; Brain; Brain Ischemia; Double-Blind Method; Female; | 2020 |
Safety and efficacy of pregabalin in patients with central post-stroke pain.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Dose-Response Relationship, Drug; Double-Blind Method; F | 2011 |
[Comparative study on effects between electroacupuncture and acupuncture for spastic paralysis after stroke].
Topics: Acupuncture Therapy; Electroacupuncture; gamma-Aminobutyric Acid; Glutamic Acid; Muscle Spasticity; | 2012 |
Gabapentin in late-onset poststroke seizures.
Topics: Acetates; Aged; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Dr | 2002 |
The prediction of malignant cerebral infarction by molecular brain barrier disruption markers.
Topics: Aged; Biomarkers; Blood-Brain Barrier; Brain; Case-Control Studies; Edema; Female; Fibronectins; gam | 2005 |
60 other studies available for gamma-aminobutyric acid and Stroke
| Article | Year |
|---|---|
Recovery of consolidation after sleep following stroke-interaction of slow waves, spindles, and GABA.
Topics: Animals; Electroencephalography; gamma-Aminobutyric Acid; Memory Consolidation; Rats; Sleep; Stroke | 2022 |
Acupuncture alleviates spinal hyperreflexia and motor dysfunction in post-ischemic stroke rats with spastic hypertonia via KCC2-mediated spinal GABA
Topics: Acupuncture Therapy; Animals; gamma-Aminobutyric Acid; Humans; Ischemic Stroke; Muscle Hypertonia; M | 2022 |
Acupuncture improves the structure of spastic muscle and decreases spasticity by enhancing GABA, KCC2, and GABAAγ2 in the brainstem in rats after ischemic stroke.
Topics: Acupuncture Therapy; Animals; Brain Stem; gamma-Aminobutyric Acid; Infarction, Middle Cerebral Arter | 2022 |
[Effect of electroacupuncture of Governor Vessel on expression of GAD67 and GABA-T in cerebral cortex of rats with post-stroke limb spasticity].
Topics: Animals; Brain Ischemia; Cerebral Cortex; Electroacupuncture; gamma-Aminobutyric Acid; Glutamate Dec | 2022 |
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy.
Topics: Amines; Analgesics; Cardiovascular Diseases; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gab | 2022 |
Ischemic stroke rehabilitation through optogenetic modulation of parvalbumin neurons in the contralateral motor cortex.
Topics: Animals; gamma-Aminobutyric Acid; Humans; Infarction, Middle Cerebral Artery; Ischemic Stroke; Motor | 2023 |
Ischemic stroke rehabilitation through optogenetic modulation of parvalbumin neurons in the contralateral motor cortex.
Topics: Animals; gamma-Aminobutyric Acid; Humans; Infarction, Middle Cerebral Artery; Ischemic Stroke; Motor | 2023 |
Ischemic stroke rehabilitation through optogenetic modulation of parvalbumin neurons in the contralateral motor cortex.
Topics: Animals; gamma-Aminobutyric Acid; Humans; Infarction, Middle Cerebral Artery; Ischemic Stroke; Motor | 2023 |
Ischemic stroke rehabilitation through optogenetic modulation of parvalbumin neurons in the contralateral motor cortex.
Topics: Animals; gamma-Aminobutyric Acid; Humans; Infarction, Middle Cerebral Artery; Ischemic Stroke; Motor | 2023 |
GABA and Glutamate in hMT+ Link to Individual Differences in Residual Visual Function After Occipital Stroke.
Topics: gamma-Aminobutyric Acid; Glutamic Acid; Humans; Individuality; Magnetic Resonance Imaging; Photic St | 2023 |
[Effects of Governor Vessel electroacupuncture on chloridion homeostasis in the cortex of rats with limb spasm after cerebral ischemia-reperfusion].
Topics: Animals; Baclofen; Cerebral Cortex; Cerebral Infarction; Electroacupuncture; gamma-Aminobutyric Acid | 2023 |
Waggle needling wields preferable neuroprotective and anti-spastic effects on post-stroke spasticity rats by attenuating γ-aminobutyric acid transaminase and enhancing γ-aminobutyric acid.
Topics: 4-Aminobutyrate Transaminase; Acupuncture Therapy; Animals; Brain Ischemia; gamma-Aminobutyric Acid; | 2020 |
[Stress-induced disorders].
Topics: Dizziness; gamma-Aminobutyric Acid; Humans; Stress, Physiological; Stroke | 2020 |
Excessive Astrocytic GABA Causes Cortical Hypometabolism and Impedes Functional Recovery after Subcortical Stroke.
Topics: Animals; Astrocytes; Cerebral Cortex; gamma-Aminobutyric Acid; Glucose; Male; Models, Biological; Mo | 2020 |
Environmental enrichment implies GAT-1 as a potential therapeutic target for stroke recovery.
Topics: Animals; Disease Models, Animal; Female; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric | 2021 |
Improvement of Antioxidant Defences and Mood Status by Oral GABA Tea Administration in a Mouse Model of Post-Stroke Depression.
Topics: Affect; Animals; Depression; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamates; Glutamic A | 2017 |
Proteomic analysis of postsynaptic proteins in regions of the human neocortex.
Topics: Animals; Computational Biology; Female; gamma-Aminobutyric Acid; Humans; Image Processing, Computer- | 2018 |
Delayed inhibition of tonic inhibition enhances functional recovery following experimental ischemic stroke.
Topics: Animals; Brain Ischemia; Cognition; gamma-Aminobutyric Acid; Hippocampus; Long-Term Potentiation; Ma | 2019 |
Functional relevance of stroke-related losses in GABA
Topics: gamma-Aminobutyric Acid; Humans; Recovery of Function; Stroke | 2018 |
The Influence of Primary Motor Cortex Inhibition on Upper Limb Impairment and Function in Chronic Stroke: A Multimodal Study.
Topics: Aged; Aged, 80 and over; Chronic Disease; Electromyography; Evoked Potentials, Motor; Female; gamma- | 2019 |
Predicting behavioural response to TDCS in chronic motor stroke.
Topics: Adult; Aged; Aged, 80 and over; Electric Stimulation Therapy; Evoked Potentials, Motor; Female; gamm | 2014 |
Effects of medullary administration of a nitric oxide precursor on cardiovascular responses and neurotransmission during static exercise following ischemic stroke.
Topics: Animals; Arginine; Cardiovascular System; Female; gamma-Aminobutyric Acid; Glutamic Acid; Infarction | 2013 |
Comparative efficacy of pregabalin and therapeutic ultrasound versus therapeutic ultrasound alone on patients with post stroke shoulder pain.
Topics: Adult; Aged; Analgesics; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pregabalin; Sho | 2014 |
Post-stroke pain hypersensitivity induced by experimental thalamic hemorrhage in rats is region-specific and demonstrates limited efficacy of gabapentin.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Disease Models, Animal; Gabapentin; gamma- | 2014 |
Effect of catgut implantation at acupoints on GABA(B) and mGluR1 expressions in brain stem of rats with spasticity after stroke. .
Topics: Acupuncture Points; Acupuncture Therapy; Animals; Brain Stem; Catgut; Disease Models, Animal; gamma- | 2014 |
The role of calcitonin gene-related peptide in post-stroke depression in chronic mild stress-treated ischemic rats.
Topics: Anhedonia; Animals; Antidepressive Agents; Brain Ischemia; Calcitonin Gene-Related Peptide; Chronic | 2015 |
Thrombolytic treatment decreases glutamate/GABA ratio in serum during acute ischaemic stroke: a pilot study.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Female; Fibrinolytic Agents; gamma-Aminobutyric Acid; Gluta | 2015 |
Striatal astrocytes transdifferentiate into functional mature neurons following ischemic brain injury.
Topics: Animals; Astrocytes; Brain Ischemia; Choline O-Acetyltransferase; Corpus Striatum; Disease Models, A | 2015 |
[The principles of pharmacotherapy of poststroke shoulder pain].
Topics: Amines; Amitriptyline; Anti-Inflammatory Agents; Clonidine; Cyclohexanecarboxylic Acids; Drug Therap | 2015 |
Regulation of GABA Neurotransmission by Glutamic Acid Decarboxylase (GAD).
Topics: Animals; Calpain; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Humans; Phosphorylation; Protein | 2015 |
A Medication Combination for the Treatment of Central Poststroke Pain via the Adjuvant Use of Prednisone With Gabapentin: A Case Report.
Topics: Adult; Amines; Analgesics; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Thera | 2016 |
Cortical Excitability Measured with nTMS and MEG during Stroke Recovery.
Topics: Aged; Aged, 80 and over; Beta Rhythm; Cerebral Cortex; Cortical Synchronization; Evoked Potentials, | 2015 |
Antidepressive-like effects and antioxidant activity of green tea and GABA green tea in a mouse model of post-stroke depression.
Topics: Animals; Antidepressive Agents; Antioxidants; Brain; Camellia sinensis; Depression; Disease Models, | 2016 |
Gabapentinoid Insensitivity after Repeated Administration is Associated with Down-Regulation of the α(2)δ-1 Subunit in Rats with Central Post-Stroke Pain Hypersensitivity.
Topics: Amines; Analgesics; Animals; Blotting, Western; Calcium Channels; Cyclohexanecarboxylic Acids; Disea | 2016 |
PHYSIOLOGY. A fish back from the dead.
Topics: Anaerobiosis; Animals; Fundulidae; gamma-Aminobutyric Acid; Humans; Hypoxia; MicroRNAs; Oxygen; Stro | 2016 |
Cortical excitability in chronic stroke and modulation by training: a TMS study.
Topics: Adult; Aged; Brain Mapping; Cerebral Cortex; Chronic Disease; Electromyography; Evoked Potentials, M | 2009 |
Modeling subpopulations with the $MIXTURE subroutine in NONMEM: finding the individual probability of belonging to a subpopulation for the use in model analysis and improved decision making.
Topics: Algorithms; Anticonvulsants; Chlormethiazole; Computer Simulation; Decision Making; Decision Support | 2009 |
Deficient intracortical inhibition (SICI) during movement preparation after chronic stroke.
Topics: Aged; Electromyography; Female; gamma-Aminobutyric Acid; Hand; Humans; Middle Aged; Motor Cortex; Mo | 2009 |
Neurotransmitter synthesis in poststroke cortical neurogenesis in adult rats.
Topics: Acetylcholine; Animals; Animals, Newborn; Bromodeoxyuridine; Cerebral Cortex; Choline O-Acetyltransf | 2010 |
A silver lining to stroke: does ischemia generate new cortical interneurons?
Topics: Adult Stem Cells; Animals; Brain Ischemia; Cell Cycle; Cell Movement; Cell Proliferation; Cerebral C | 2010 |
Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke.
Topics: Animals; Benzodiazepines; Cerebral Infarction; Disease Models, Animal; Drug Inverse Agonism; GABA An | 2010 |
Stroke: recovery inhibitors under attack.
Topics: Animals; Cerebral Infarction; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Mice | 2010 |
Pregabalin suppresses calcium-mediated proteolysis and improves stroke outcome.
Topics: Animals; Calcium; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Male; Mice; Mice, Inbre | 2011 |
Is pregabalin ineffective in poststroke pain?
Topics: Analgesics; gamma-Aminobutyric Acid; Humans; Pain; Pregabalin; Stroke | 2011 |
Successful amelioration of tinnitus in a stroke patient by low-dose gabapentin.
Topics: Amines; Audiometry, Pure-Tone; Basal Ganglia Hemorrhage; Cerebral Angiography; Cyclohexanecarboxylic | 2012 |
Impact of ventralis caudalis deep brain stimulation combined with stereotactic bilateral cingulotomy for treatment of post-stroke pain.
Topics: Amines; Analgesics; Combined Modality Therapy; Cyclohexanecarboxylic Acids; Deep Brain Stimulation; | 2012 |
Painted turtle cortex is resistant to an in vitro mimic of the ischemic mammalian penumbra.
Topics: Action Potentials; Animals; Brain Ischemia; Cell Survival; Cerebral Cortex; Cerebrovascular Circulat | 2012 |
Neurounina-1, a novel compound that increases Na+/Ca2+ exchanger activity, effectively protects against stroke damage.
Topics: Animals; Benzodiazepinones; Calcium; Cell Death; Cells, Cultured; Cricetinae; Dogs; Flumazenil; GABA | 2013 |
Central post-stroke pain syndrome: yet another use for gabapentin?
Topics: Acetates; Activities of Daily Living; Administration, Oral; Amines; Analgesics; Cyclohexanecarboxyli | 2002 |
Reduced inhibition within primary motor cortex in patients with poststroke focal motor seizures.
Topics: Electric Stimulation; Electromagnetic Fields; gamma-Aminobutyric Acid; Humans; Interneurons; Motor C | 2003 |
An East-West approach to the management of central post-stroke pain.
Topics: Acetates; Acupuncture; Aged; Amines; Amitriptyline; Analgesics, Opioid; Antidepressive Agents, Secon | 2003 |
Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study.
Topics: Analysis of Variance; Animals; Asparagine; Aspartic Acid; Brain Ischemia; Cerebral Hemorrhage; Chrom | 2003 |
[Changes in adaptation-compensatory processes in the course of acute ischemic stroke (clinico-biochemical comparisons)].
Topics: Acid Phosphatase; Acute Disease; Adaptation, Physiological; Excitatory Amino Acids; Female; gamma-Am | 2003 |
Neurotransmitter release in experimental stroke models: the role of glutamate-GABA interaction.
Topics: Action Potentials; Animals; Brain; D-Aspartic Acid; Disease Models, Animal; Excitatory Amino Acid An | 2004 |
Successful use of zonisamide for central poststroke pain.
Topics: Anticonvulsants; Calcium Channel Blockers; Calcium Channels, T-Type; Cerebral Infarction; Diabetes C | 2004 |
American Chemical Society--227th annual meeting. Neuroprotection. 28 March - 1 April 2004, Anaheim, CA, USA.
Topics: Animals; Antiparkinson Agents; Carbazoles; gamma-Aminobutyric Acid; Humans; Indoles; Neuroprotective | 2004 |
Prolonged moderate hypothermia in massive hemispheric infarction: clinical experience.
Topics: Adult; Cerebral Infarction; Female; gamma-Aminobutyric Acid; Humans; Hypotension; Hypothermia, Induc | 2005 |
Failure of ischemic neuroprotection by potentiators of gamma-aminobutyric acid.
Topics: Animals; Anticonvulsants; Brain Ischemia; Disease Models, Animal; Fructose; gamma-Aminobutyric Acid; | 2003 |
GABA in ischemic stroke. Proton magnetic resonance study.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Case-Control Studies; Female; gamma-Aminobutyric Acid; Huma | 2004 |
Survey of management of acquired nystagmus in the United Kingdom.
Topics: Amines; Baclofen; Cyclohexanecarboxylic Acids; Drug Utilization; Excitatory Amino Acid Antagonists; | 2007 |
Gabapentin treatment in a child with delayed-onset hemichorea/hemiballismus.
Topics: Acetates; Adolescent; Age of Onset; Amines; Antiparkinson Agents; Basal Ganglia; Chorea; Cyclohexane | 2000 |
Neuroprotective efficacy of AR-A008055, a clomethiazole analogue, in a global model of acute ischaemic stroke and its effect on ischaemia-induced glutamate and GABA efflux in vitro.
Topics: Animals; Brain Ischemia; Chlormethiazole; Female; gamma-Aminobutyric Acid; Gerbillinae; Glutamic Aci | 2001 |
Aniracetam enhances glutamatergic transmission in the prefrontal cortex of stroke-prone spontaneously hypertensive rats.
Topics: Amino Acids; Amygdala; Animals; Cerebral Infarction; Extracellular Space; gamma-Aminobutyric Acid; G | 2002 |